Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy

ConclusionsNLR-5 deserves prospective validation to identify mUC patients with poor prognosis following ICIs.
Source: Clinical and Translational Oncology - Category: Cancer & Oncology Source Type: research